LQDA
Drug Manufacturers - Specialty & Generic · Healthcare
CEO
Equibles does not estimate personal net worth.
Earlier roles on record: CEO at Liquidia Corp (LQDA) until December 14, 2020. The proxy statement of Liquidia Corp reports total compensation of $1,082,252 for Neal Fowler in fiscal 2020, including a base salary of $541,872. Disclosed compensation is on record for 2 fiscal years. Neal Fowler has spoken on 2 earnings calls across 1 company, most recently for Liquidia Corp on September 30, 2020. The companies whose calls Neal Fowler spoke on are classified in the Healthcare sector.
“On the call with me today are Steve Bariahtaris, our Interim Chief Financial Officer, as well as other senior members of our company who are available to answer questions, if needed.”
“On the call with me today are Rich Katz, our Chief Financial Officer; Tushar Shah, our Chief Medical Officer who joined us in May, as well as other senior members of the company who are available to answer questions, if needed.”
Start not stated–2020-12-14
LQDA
Drug Manufacturers - Specialty & Generic · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Liquidia Corp (LQDA) | Former Chief Executive Officer | $541,872 | $1,082,252 |
| 2019 | Liquidia Corp (LQDA) | Former Chief Executive Officer | $508,246 | $1,729,088 |